This content is machine translated Psoriatic Arthritis 5-year long-term data on apremilast are convincing Many patients with psoriatic arthritis (PsA) suffer from chronic symptoms and need permanent relief from their symptoms. Two pooled analyses based on data from the PALACE trial program show that…
View Post 3 min This content is machine translated Recommendations of the DGRh Interrupt rheumatism therapy only briefly before operations The increased risk of infection after surgical procedures necessitates temporary adjustment of basic anti-inflammatory therapy in patients with rheumatic diseases. However, medication breaks may be shortened based on new study…
View Post 8 min This content is machine translated Vulvar and vaginal carcinoma Update: precancerous lesions, classification and therapy While vaginal cancer is a rarity, cases of vulvar cancer have increased significantly worldwide over the past 20 years. It is the female carcinoma whose incidence is increasing most rapidly.…
View Post 3 min This content is machine translated Neuropathic pain With nerve regeneration comes chronic pain Even healed nerve injuries often leave chronic pain and hypersensitivity to gentle touch. Scientists at the Institute of Pharmacology and the Institute of Anatomy and Cell Biology at the Medical…
View Post 15 min This content is machine translated Pediatric pneumology Growing up after lung transplantation Lung transplantation (Lutx) is also an established therapeutic option in childhood and adolescence when, despite exhaustion of all available therapeutic measures, a severe disease progresses, quality of life is significantly… CME-Test
View Post 3 min This content is machine translated Corona protection and skin health Mask dermatitis – expert tips for prophylaxis and treatment During the corona pandemic, an increase in facial skin lesions was observed due to the wearing of a mouth-nose protection. Wearing an FFP2 protective mask will continue to be recommended…
View Post 2 min This content is machine translated Breast Cancer Regulatory extension for anti-PD-1 therapy with pembrolizumab Swissmedic has granted a further marketing authorization for anti-PD-1 therapy with pembrolizumab. This can now be approved in combination with chemotherapy in Switzerland for the treatment of patients with locally…
View Post 3 min This content is machine translated Long-term management of psoriasis Biologics have improved the supply situation Psoriasis registries and care studies are an important source of data for evidence-based systems therapy. Convincing long-term data are now available, particularly for the anti-IL-17 and anti-IL-23 antibodies. These have also…
View Post 4 min This content is machine translated Iron deficiency Update anemia workup: what, when, and why? Iron deficiency anemia is common – especially in elderly patients with renal insufficiency or malnutrition. As a rule, a multifactorial process can be assumed. Therefore, a number of different causes…
View Post 2 min This content is machine translated Comorbidity Research Chronic urticaria: increased prevalence of mental disorders. According to a secondary analysis, almost one in three patients with chronic urticaria suffers from at least one mental disorder. Sleep-wake cycle impairments are most common, followed by anxiety disorders…
View Post 3 min This content is machine translated Relapsing-remitting multiple sclerosis (RRMS) New S1P1 modulator expands the therapeutic spectrum The selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod has been approved in Switzerland since November 2021 for the treatment of relapsing-remitting multiple sclerosis (RRMS) with active disease. The approval is…
